Clinical Trials Directory

Trials / Completed

CompletedNCT02015260

A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts

A Randomised, Multicentre, Double-blind, Placebo-controlled, Dose-ranging Trial to Evaluate the Efficacy, Safety and Tolerability of Three Dose Regimens of Topical Nitric Oxide in Patients With Anogenital Warts

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
299 (actual)
Sponsor
University of Aberdeen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Objective To assess the efficacy of the topical application of Nitric Oxide, delivered using acidified nitrite. Design Multicentre, randomized, controlled, dose ranging trial. A control arm and three doses of acidified nitrite applied topically for 12 weeks with a further 12 weeks of follow up. Setting The trial setting was in European genitourinary medicine clinics Participants Male and female volunteers over 18 years of age with between 2 and 50 ano-genital warts, 328 were screened for eligibility and 299 subjects from 40 centres were randomised. Exclusions Pregnancy; concomitant Sexually Transmitted Disease; internal warts requiring treatment other than surgery /laser; diabetes ; Human Immunodeficiency Virus-positive, immunosuppressed and/or using immunosuppressive therapies; drug abuse. interventions compared * Control Placebo nitrite cream and placebo citric acid cream twice daily * A) 3% sodium nitrite + 4.5% citric acid creams twice daily * B) 6% sodium nitrite + 9% citric acid creams once daily * C) 6% sodium nitrite + 9% citric acid creams twice daily Outcomes * Primary proportion of patients with complete clearance of target warts Secondary * Time to clearance * Wart area * Wart count * Patient and investigator assessment of efficacy * Safety * Tolerability * Adherence

Conditions

Interventions

TypeNameDescription
DRUGTopical NOVarying doses of sodium nitrite and citric acid co-applied to warts
DRUGPlaceboPlacebo

Timeline

Start date
2001-09-01
Primary completion
2003-05-01
Completion
2003-05-01
First posted
2013-12-19
Last updated
2017-05-03

Source: ClinicalTrials.gov record NCT02015260. Inclusion in this directory is not an endorsement.